Market Place
Sourcing Support
Crown Bio San Diego Gains CLIA Certification for Clinical Trials
22 Jul 2025 //
BUSINESSWIRE
Crown Bioscience Wins Fierce CRO Award for Global Operations
24 Jun 2025 //
BUSINESSWIRE
Crown Bioscience Achieves Green Lab Sustainability Certification
07 May 2025 //
BUSINESSWIRE
Crown Bioscience and NEXT Oncology Cement Partnership Extension
01 May 2025 //
BUSINESSWIRE
Crown Bioscience Launches 3D Bone Marrow Models at AACR
28 Apr 2025 //
BUSINESSWIRE
Crown Bioscience Appoints John Gu as Chief Executive Officer
13 Mar 2025 //
BUSINESSWIRE
Crown Bioscience Wins 2024 Fierce CRO Award for Client Service
11 Dec 2024 //
BUSINESSWIRE
Crown Bioscience Expands Singapore Facility With New Capabilities
01 Oct 2024 //
BUSINESSWIRE
Crown Bioscience Partners With CTI For Oncology Drug Development
21 Aug 2024 //
BUSINESSWIRE
Crown Bioscience Achieves CAP, ISO 15189 Accreditations
11 Apr 2024 //
BUSINESSWIRE
Crown Announces New Preclinical and Translational Oncology Data at AACR 2024
28 Mar 2024 //
BUSINESSWIRE
Crown Bio Recognized Once Again as T+ Employer for the Third Year in a Row
18 Mar 2024 //
BUSINESSWIRE
Crown Bioscience`s Global Oncology Research Facilities Achieve Prestigious ISO
23 Jan 2024 //
BUSINESSWIRE
Crown Bioscience Introduces OrganoidXplore
07 Nov 2023 //
BUSINESSWIRE
Crown Bioscience, HanX pact shows promise of lymphoma drug
24 Aug 2023 //
FIERCE BIOTECH
Crown Bio Enables HanX Biopharmaceutical to Progress HX009 to Clinical Trials
22 Aug 2023 //
BUSINESSWIRE
Crown Announces Transaction Closing of Indivumed’s Service Business
04 Apr 2023 //
BUSINESSWIRE
Crown Bioscience Opens Singapore Lab, Partners with JSR Life Sciences
10 Mar 2023 //
CONTRACT PHARMA
Crown Opens Singapore Laboratory and Establishes Local Commercial Partner
09 Mar 2023 //
BUSINESSWIRE
Crown Bioscience, JSR team to acquire IndivuServ unit
31 Jan 2023 //
FIERCE BIOTECH
Crown Bioscience to Acquire Indivumed’s Service Business and Supporting Biobank
25 Jan 2023 //
BUSINESSWIRE
Crown Publishes Study in PLOS ONE Highlighting the Use of Clinically Relevant 3D
05 Jan 2023 //
BUSINESSWIRE
Crown Bioscience inks deal with ERS for gene editing technology
12 Dec 2022 //
FIERCEBIOTECH
Crown and ERS Genomics Announce Global CRISPR/Cas9 Licensing Agreement
08 Dec 2022 //
BUSINESSWIRE
Crown Bioscience, ERS Genomics Ink Global CRISPR/Cas9 Licensing Agreement
08 Dec 2022 //
CONTRACTPHARMA
Crown Bioscience Appoints Michael Prosser as CBO
28 Jul 2022 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.